Literature DB >> 2543990

Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors.

H A Baldwin1, S E File.   

Abstract

The purpose of this study was to determine the mechanism by which caffeine increases anxiety. Rats were tested in the social interaction test of anxiety after administration of caffeine (20 or 40 mg/kg) alone or in combination with various compounds. In order to investigate the role of adenosine receptors, caffeine was given in combination with 2-chloroadenosine (0.1 and 1 mg/kg). To investigate the role of benzodiazepine receptors, chlordiazepoxide (5 mg/kg), a benzodiazepine antagonist, flumazenil (RO 15-1788, 1 and 10 mg/kg) and a triazolobenzodiazepine U-43,465 (32 mg/kg) were used. Finally, an alpha 2-receptor agonist, clonidine (0.1 and 0.025 mg/kg) and a beta-adrenoceptor antagonist, DL-propranolol (5 mg/kg), were used to study the role of noradrenergic systems in the effects of caffeine. Caffeine (20 and 40 mg/kg) reduced the time spent in social interaction and this effect was antagonized by chlordiazepoxide, U-43,465 and DL-propranolol, but not by flumazenil, 2-chloroadenosine or clonidine. It was therefore concluded that the anxiogenic effect of caffeine was unlikely to be due to its effects at adenosine or benzodiazepine receptors. It is suggested that the reversal of caffeine's effects by chordiazepoxide may have been "functional," i.e., merely a cancellation of two opposite effects. It is discussed whether the reversal of caffeine's effects by propranolol and U-43,465 are functional, or reflect a noradrenergic site of action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543990     DOI: 10.1016/0091-3057(89)90230-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  18 in total

1.  Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.

Authors:  G Griebel; M Saffroy-Spittler; R Misslin; D Remmy; E Vogel; J J Bourguignon
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Injection of Cocaine-Amphetamine Regulated Transcript (CART) peptide into the nucleus accumbens does not inhibit caffeine-induced locomotor activity: Implications for CART peptide mechanism.

Authors:  Martin O Job
Journal:  Pharmacol Biochem Behav       Date:  2016-05-07       Impact factor: 3.533

3.  The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice.

Authors:  J Chen; L Rinaldo; S-J Lim; H Young; R O Messing; D-S Choi
Journal:  Genes Brain Behav       Date:  2007-03-21       Impact factor: 3.449

4.  Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in mice.

Authors:  G Griebel; M Saffroy-Spittler; R Misslin; E Vogel; J R Martin
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Molecular pathways of anxiety revealed by knockout mice.

Authors:  S J Wood; M Toth
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

6.  Effects of anxiogenic drugs on the emission of 22- and 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Maria Willadsen; Laura M Best; Markus Wöhr; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

7.  Anxiolytic activity of adenosine receptor activation in mice.

Authors:  N Jain; N Kemp; O Adeyemo; P Buchanan; T W Stone
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats.

Authors:  M D S Lapiz-Bluhm; C O Bondi; J Doyen; G A Rodriguez; T Bédard-Arana; D A Morilak
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

9.  Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics.

Authors:  C E Lau; J Wang
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

10.  Central effects of corticotropin releasing factor (CRF): evidence for similar interactions with environmental novelty and with caffeine.

Authors:  D R Britton; E Indyk
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.